Learn how quickly you can expect relief from Klonopin, a benzodiazepine medication commonly prescribed for anxiety and ...
Of more than 2,600 US healthcare workers who participated in a nationwide online panel survey from 2022 to 2023, 26% reported ...
How the FDA and CMS worked together on a new approach to paying for digital mental health treatments
By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...
For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...
I’ve lived with anxiety disorders for as long as I can remember. My sister has struggled with them too. Looking ...
The emergency department, while sophisticated and able to treat a variety of medical issues, is not always equipped to ...
Is it anxiety or a panic attack? Discover the key differences and learn why understanding them matters for managing your ...
Johnson & Johnson (J&J) has agreed to pay $132 per share to acquire Intra-Cellular Therapies Inc. in a deal valued at about $14.6 billion, taking ownership of Caplyta (lumateperone), a once-daily oral ...
It’s hard to know how long anxiety disorders will last when you’re in the thick of them. It was during the mid-2000s that my ...
Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback